|
ZNF563 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.68941999999506E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.27050000001228E-06 |
| Normal-vs-Stage2 |
1.585730E-04 |
| Normal-vs-Stage3 |
9.79610000000353E-05 |
| Normal-vs-Stage4 |
3.49840000002377E-06 |
| Stage1-vs-Stage2 |
6.670000E-01 |
| Stage1-vs-Stage3 |
4.227200E-01 |
| Stage1-vs-Stage4 |
3.131800E-02 |
| Stage2-vs-Stage3 |
8.193000E-01 |
| Stage2-vs-Stage4 |
9.185500E-02 |
| Stage3-vs-Stage4 |
1.871380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.12069999999676E-05 |
| Normal-vs-AfricanAmerican |
6.836000E-04 |
| Normal-vs-Asian |
1.506070E-02 |
| Caucasian-vs-AfricanAmerican |
5.425000E-01 |
| Caucasian-vs-Asian |
8.277400E-01 |
| AfricanAmerican-vs-Asian |
6.709200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97335999999604E-05 |
| Normal-vs-Female |
1.006010E-04 |
| Male-vs-Female |
9.919600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.952400E-04 |
| Normal-vs-Extreme_Weight |
2.5827999999839E-06 |
| Normal-vs-Obese |
1.223310E-03 |
| Normal-vs-Extreme_Obese |
1.924610E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.854200E-01 |
| Normal_Weight-vs-Obese |
4.006000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.500400E-01 |
| Extreme_Weight-vs-Obese |
2.115000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.587400E-01 |
| Obese-vs-Extreme_Obese |
3.818200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.85929999999757E-05 |
| Normal-vs-Age(41-60Yrs) |
1.278730E-03 |
| Normal-vs-Age(61-80Yrs) |
2.84949999995732E-06 |
| Normal-vs-Age(81-100Yrs) |
4.174200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.492200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.763600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.140200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.854960E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.475400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.451600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.237040E-04 |
| Normal-VS-Type2 PRCC |
1.62510000012439E-07 |
| Normal-VS-KIRP CIMP |
2.46260000003051E-06 |
| Normal-VS-Unclassified PRCC |
1.192160E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.134300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.861800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.532200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.634300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.421350E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.881600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.06979999992785E-07 |
| Normal-vs-N1 |
7.86690000000867E-05 |
| Normal-vs-N2 |
3.63239999999765E-05 |
| N0-vs-N1 |
8.470000E-01 |
| N0-vs-N2 |
1.757800E-02 |
| N1-vs-N2 |
5.095700E-02 |
|
|
